Study of Chicory per oral administration effect in decreasing serum Ferritin level in major and intermediate beta thalassemia patient.

Investigation the effectiveness and non effectiveness of oral administration of chicory extract on the decrease of ferritin serum in patients with thalassemia major and intermedia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016112514333N61

Enrollment

100

Registered

2017-03-05

Start date

2017-02-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Thalassemia. Beta thalassaemia

Interventions

Intervention 1: Patients in the intervention group will receive 200 mg of chicory syrup daily as a supplemental therapy along with iron chelation. Intervention 2: In the control group 200 mg placebo w

Treatment - Drugs

Placebo

Patients in the intervention group will receive 200 mg of chicory syrup daily as a supplemental therapy along with iron chelation.

In the control group 200 mg placebo will be prescribed in addition to iron chelation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with thalassemia major; Patients with serum ferritin between 1000 and 3000. Exclusion criteria: Patients with heart failure, hypertension and diabetes; Patients who have more than 3,000 ferritin in routine check

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum ferritin levels. Timepoint: Baseline, two months after the start of treatment and two months after the end of treatment. Method of measurement: Based on lab.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farzaneh Roostaei

Kermanshah University of Medical Sciences

froosatei1985@gmail.com+98 83 3721 7206

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026